Changes in the receptor-G protein-adenylyl cyclase system in heart failure from various types of heart muscle disease
- 1 January 1992
- book chapter
- review article
- Published by Springer Science and Business Media LLC
Abstract
The abnormalities of the receptor-G protein-adenylyl cyclase (RCG) system in failing human myocardium as the result of 1) idiopathic dilated cardiomyopathy (IDC), 2) ischemic dilated cardiomyopathy (ISCDC), and 3) primary pulmonary hypertension (PPH) were investigated. Depending on the etiology of heart failure, abnormalities of the RCG system result from a reduced number of β 1 receptors, uncoupling of β 1 or β 2 receptors, alteration of G protein function, or decreased catalytic subunit activity of adenylyl cyclase. Compared to IDC, receptor down-regulation is less pronounced in ISCDC, and slightly more pronounced in PPH. Preliminary data suggest that β 1 receptor down-regulation results from alteration in steady-state receptor mRNA levels. Increased functional activity of Gi protein, which seems to result from posttranslational modification, is observed in IDC and ISCDC. Altered Gi protein function may be the basis for β-receptor uncoupling in IDC and ISCDC, whereas in PPH, this phenomenon may result from altered adenylyl cyclase function. Catalytic subunit activity of adenylyl cyclase is decreased in order of increasing pulmonary hypertension in right-ventricular preparations from PPH > IDC > ISCDC. However, catalytic subunit activity is similar in LV preparations from all three groups. The decrease in adenylyl cyclase catalytic subunit activity may be the result of the marked cellular injury produced by pressure overload. In summary, numerous desensitization phenomena occur in the failing human heart that are etiology- or model-dependent. To a certain extent, these changes are teleologically beneficial, as they are able to partially protect the failing heart from potentially toxic adrenergic stimuli.Keywords
This publication has 27 references indexed in Scilit:
- Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms.JCI Insight, 1992
- Localization of a “postreceptor” defect in human dilated cardiomyopathyThe American Journal of Cardiology, 1989
- Mechanism of noradrenaline-induced heterologous desensitization of adenylate cyclase stimulation in rat heart muscle cells: increase in the level of inhibitory G-protein α-subunitsEuropean Journal of Pharmacology: Molecular Pharmacology, 1989
- Direct G-Protein Regulation of Ca2+ChannelsAnnals of the New York Academy of Sciences, 1989
- Altered expression of α-subunits of G proteins in failing human heartsJournal of Molecular and Cellular Cardiology, 1989
- $beta;-Adrenergic function in heart muscle disease and heart failureJournal of Molecular and Cellular Cardiology, 1985
- Evidence from use of neuronal uptake inhibition that β1-adrenoceptors, but not β2-adrenoceptors, are innervatedJournal of Pharmacy and Pharmacology, 1982
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist PirbuterolNew England Journal of Medicine, 1981
- Subcellular basis of cardiac contractile failureJournal of Molecular and Cellular Cardiology, 1978